Jerome Groopman from the New Yorker writes on how these bugs may be more of a threat than MRSA.

Also find out why antimicrobials are hitting a dead end with pharmaceutical companies:

Drug companies are looking for blockbuster therapies that must be taken daily for decades, drugs like Lipitor, for high cholesterol, or Zyprexa, for psychiatric disorders, used by millions of people and generating many billions of dollars each year. Antibiotics are used to treat infections, and are therefore prescribed only for days or weeks.

Why worry about superbugs when you have all those kids with ADHD to treat?

There’s no profit in antimicrobials and vaccines. In the face of increasingly drug-resistant bacteria, what we have now is basically it for the foreseeable future. Scary.

(via Buckeye Surgeon)